Menarini Signs A European Distribution Deal With Bouty Healthcare

In late December 2009, Bouty Healthcare announced that it had signed a distribution agreement with Menarini Diagnostics. The five-year contract concerns the European distribution of a panel of 21 tests used for diagnosis of autoimmune diseases. BMI commends Bouty Healthcare's partnership with Menarini. With its significant pan-European presence, Menarini is the fourth-largest pharmaceutical team delivering medical information to physicians.

To read the full article, please choose one of the following options: